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INTRODUCTION
Blood transfusion is the process of infusion of blood
and blood products into an individual’s circulatory
system. Blood transfusion is used in a variety of medical
conditions to replace lost components of the blood.
Component therapy whereby components of the
blood such as red cell concentrate, fresh frozen plasma,
cryoprecipitate, and platelet concentrate are infused as
indicated, has overtaken the old practice of whole
blood infusion. The science of blood transfusion dates
back to the first decade of  the 19th century, with the
discovery of distinct blood types leading to the practice
of mixing some blood from the donor and the
recipient before the transfusion (ref). Blood transfusion
need in the neonate is huge because of reduced
marrow activity in the neonatal period.1 Other
indications include replacement of losses due to blood
loss in the course of taking blood samples for various
tests, correction of anaemia, exchange blood
transfusion or partial exchange transfusions for removal
of bilirubin, removal of antibodies and replacement
of  red cells. Blood products such as platelets
concentrates and fresh frozen plasma can also be
transfused in septicaemic neonates with DIC and
neonates with bleeding diathesis2.In spite of wide use
of blood and blood products in the neonatal period,
there is paucity of local data on the pattern, indications
and reactions to blood transfusions in Nigerian
newborns. This study evaluates the blood transfusion
indications and patterns in neonates admitted to




The study was carried out at the Special Care Baby
Unit (SCBU) and C1 2nd wards of the Department of
Paediatrics, University College Hospital (UCH) Ibadan,
Nigeria. Ibadan is the capital of Oyo state located in
the southwest zone of  Nigeria. The UCH serves as
the referral centre to all primary and secondary health
facilities located in Oyo state and even other states in
the southwest and other zones. The SCBU admits
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ABSTRACT
Background and objectives: There is a huge need for blood transfusion
in the newborn particularly due to the reduced marrow activity in the
neonatal period. Despite widely use of blood products in the neonatal
period, there is paucity of  local data on the pattern, indications and
reactions to blood transfusions in Nigerian newborns. This study
evaluates the blood transfusion indications and patterns in special care
baby unit and C12nd of University College Hospital, Ibadan, Nigeria.
Methodology: A cross sectional study was carried on the recruited
newborns and structured questionnaires were used to obtain bio data,
medical problems, indications for blood transfusion, type of blood
products transfused and clinical signs. Urinalysis was performed out
before and after the transfusion.
Results: A total of 100 neonates were recruited into the study with a
male: female ratio of (M: F= 1:1). The age range was 2–34 days and
their weight ranged between 0.8kg to 3.6 kg with a mean weight of 1.64
kg. The main indications for transfusion were anaemia from prematurity
& neonatal sepsis(NNS) 46%; (red cell replacement), NNS,
Disseminated intravascular coagulation(DIC) & anaemia 24%; (partial
exchange + top up + Fresh frozen plasma), neonatal jaundice(NNJ) &
anaemia 14%; (whole blood), NNJ, NNS + anaemia 6%(Blood
transfusion + Fresh frozen plasma),  NNS + anaemia 10% (whole blood).
Conclusion: Blood transfusion is still frequent in the study area and
prematurity, neonatal sepsis and jaundice rank high in the indications.
Transfusion reactions are rare in the evaluated neonates.
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babies within the first 48 hours of live that are delivered
within UCH or referred from outside while C12nd
admits both newborns and children up to 1 year of
age.
Study Subjects
All the patients involved in this study were neonates
admitted either into the SCBU or C12nd of UCH and
received blood or blood products transfusion for
medically indicated reasons. All the blood and blood
products were screened and processed by the Blood
Bank of UCH, Ibadan.
Study Type and Methods
The study was a cross sectional study carried out on
the recruited newborns in SCBU and C12nd of UCH,
between March and October 2010. Structured
questionnaires were used to obtain bio data, medical
problems, indications for blood transfusion, type of
blood products transfused and the frequency, clinical
signs before, during and after blood transfusion.
Informed consent was obtained from the care givers
of  the recruited patients. The clinical signs were
evaluated by Paediatrics Resident Doctors and a
Consultant Paediatrician (AIA) in charge of  SCBU.
All blood products were prewarmed before
transfusion and 1 ml of calcium gluconate was given
per every 100 mLs of blood exchanged. Urinalysis
was performed on all recruited neonates using multistix
urine strip before and 12–24 hours post transfusion.
Dual data entry was carried out by using Epi Data
version 8 to enable data check, cleaning and
verification. All the data were subsequently transferred
into Statistical Package for Social Sciences (SPSS)
version 17 for analysis. Frequencies were generated for




A total of 324 neonates were seen during the period
of the study out of which 100 neonates (30.8%) had
one blood product or the other and hence, were
recruited into the study. The male: female distribution
was 50: 50 (M: F= 1:1) while their ages were between
2–34 days and their weight ranged between 0.8kg to
3.6 kg with a mean weight of  1.64 kg. The distribution
of newborns according to age groups 0-7, 8-14, 15-
21, 22-28, >29 days was 19.4%, 31.6%, 24.5%, 17.3
% and 7.1% respectively. Majority of  the patients were
preterms (82 %). The gestational age and postnatal
age distribution is as shown in figures 1 and 2.
Type of blood transfusion
Forty six percent (46%) had red cell replacement, 24%
had partial exchange + top up + fresh frozen plasma,
30% had whole blood + Fresh frozen plasma.  Ninety
percent (90%) of the patients who had exchange blood
transfusion (EBT) were preterm. Platelet rich plasma
or platelet concentrate were not available for all
indicated cases during the period of  the study.
Blood group of babies and Donor
As shown in figure 3,the pattern of blood groups of
the babies were: O = 43.9%, B =13%, A = 40% &
AB =2%. The frequency of the blood groups of the
donor units were O = 65%, B=12% A= 23%.
Indications for transfusion
The patients were categorized based on the clinical
condition and the type of blood products received.
The main indications for transfusion as shown in figure
4 were anaemia from prematurity, anaemia & Neonatal
sepsis(NNS) 46%; (red cell replacement), NNS,
Disseminated intravascular coagulopathy (DIC) &
anaemia 24%; (partial exchange + top up + Fresh
frozen plasma), Neonatal Jaundice(NNJ) & anaemia
Figure 1: GA distribution
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Figure 2: Age distribution of the neonates
Figure 3: Blood group of baby versus blood group of donor
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14%; (whole blood), NNJ, NNS + anaemia 6% (Blood
transfusion + Fresh frozen plasma),  NNS + anaemia
10%.
Blood transfusion reactions
There were no noticeable rigor, rash, jaundice (post
transfusion), oliguria or haematocrit drop following
transfusion but 5% had fever (all temperatures were
not more than 20 C above preceding levels) during
transfusion. Urine analysis showed evidence of
haemosiderin and haematuria in 4 cases that also had
DIC.
DISCUSSION
Transfusion practices for high risk infants differ among
neonatal intensive care units.2-9 These practices vary as
a function of birth weight, gestational age and severity
of  illness.3-4 The safest blood transfusion is the one
not administered. When a transfusion is needed, it is
important for both physicians and nursing staff to be
aware of  its potential acute and delayedadverse effects.
Adverse consequences may be minimized throughearly
recognition and prompt therapeutic intervention.
Hence, all the babies in this study had full clinical
evaluation done pre, intra and post blood transfusion.
In addition to the issues concerning blood transfusions
in general, special considerations apply to transfusing
neonates. Neonates do not produce red blood cell
(RBC) antibodies; any antibodies present are of
maternal origin.10 Young infants’ plasma may contain
maternal antibodies to ABO blood group antigens
instead of the naturally occurring anti-ABO antibodies
normally present in older patients. This complicates
blood bank testing and selection of appropriate blood
components for transfusion. Conversely, blood bank
testing is simplified by the fact that neonates do not
make antibodies to minor erythrocyte antigens.10 All
blood transfusions carried out in these patients had
the grouping and cross matching of both mother and
baby samples. Cellular blood components may be
irradiated to prevent transfusion-associated graft-
versus-host disease, a syndrome that can affect
immunocompromised patients such as premature
infants. However, irradiation accelerates the leakage of
potassium out of stored red blood cells (RBCs),
increasing the risk or transfusion-induced arrhythmias
from hyperkalaemia and hypocalcaemia. Irradiation
was not done for any of the blood transfused in these
patients because this was not available.
Premature infants are among the most frequently
transfused groups of patients, usually receiving red
cells.3-4 This was the case here where 82% of  the patients
transfused were preterms. The vast majority of
preterm infants experience an exaggerated physiologic
anaemia primarily occurring in infants born at fewer
than 32 weeks gestation, the haemoglobin can fall to
as low as 7 g/dL by 4-6 weeks of age. This
normocytic anaemia is not associated with deficiencies
of iron, protein, vitamin E, vitamin B12, or folate and
usually improves spontaneously with time, but many
Figure 4: Indications for blood transfusion
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symptomatic infants may require treatment. The
preterm babies have a higher chance of  being admitted
with serious illnesses that will necessitate blood
investigations, therefore are predisposed to iatrogenic
anaemia. They are also more likely to be ill. Particularly,
they may have neonatal septicaemia which may also
make them prone to develop bleeding diathesis.
Another major reason is their poor bone marrow
response to anaemia.  In sick preterm infants, anaemia
of prematurity can be accentuated by nonphysiological
anaemia, characterized by a decreasing haematocrit,
reticulocytopaenia, bone marrow hypoplasia, and
endogenous erythropoietin concentrations that are
inappropriately low relative to the degree of anaemia.3,4
The most common cause of nonphysiological anaemia
is blood loss, which may be acute or chronic. A
common and potentially avoidable cause of postnatal
blood loss is iatrogenic as a result of frequent blood
sampling (phlebotomy) in sick preterm infants.3-4
About 50% of the babies transfused were within the
first 2 weeks of life and this is in keeping with the fact
that many babies that are ill will be ill in first few days
of  life. Also, the blood group of  the donors and
recipient are in keeping with the pattern general
population. This study also showed that the various
indications for transfusion are a reflection of the
national neonatal burden which includes prematurity,
neonatal sepsis and jaundice11. Late presentation to
referral centres with resultant worsening of clinical
condition and non-availability of  early intervention
methods may be responsible for the high use of blood
products in these patients. Lack of  prompt
management due to high cost of treatment and out
of pocket payment also might have played significant
role in the clinical states of the babies evaluated in this
study12. This may be responsible for rapid deterioration
of the clinical state leading to worsening of jaundice
and development of disseminated intravascular
coagulopathy. The multiple clinical conditions that these
patients presented with are also reflections of the
severity of  their clinical states.
The common blood transfusion related reactions are:
Febrile, non-haemolytic transfusion reaction (FNHTR),
allergic/urticarial/anaphylactic reaction, acute non
immune transfusion reactions and fluid overload. Acute
haemolytic transfusion reactions are the second
commonest cause of transfusion-related fatality in adult
patients, butthese are rare in neonates.13 The symptoms
of haemolysis typically seen in older patients, such as
fever, hypotension, and flank pain, usually are not
identified in the neonatal patient. In the neonate, an
acute haemolytic event may be characterized by
increased plasma free haemoglobin, haemoglobinuria,
increased potassium concentration, and decreased pH.
Results of the direct antiglobulin (Coombs) test may
confirm the presence of  an antibody on the RBC
surface. Treatment is supportive to maintain blood
pressure and renal perfusion with intravenous normal
saline at 10 to 20 mL/kg anddiuresis with furosemide.
Prevention is aimed at minimizing human errors and
improving patient safety by strict regulationson patient
identification before blood is drawn or administered.
None of the patients seen in this study developed acute
haemolytic transfusion reactions or urticarial rash.
Febrile nonhaemolytic transfusion reactions (FNHTR)
are suspected in the absence of haemolysis with an
increase in body temperatureof less than 2°C. FNHTR
occur in 0.1% to 1% of  transfusions in adults. The
temperaturerise is mediated by inflammatory cytokines
(interleukin [IL]-1, IL-6, IL-8, tumor necrosis factor)
released from white bloodcells (WBCs) during storage
of  the blood component or caused by preformed
recipient antibodies reacting with WBCs in the infused
component. Prestorage leukoreduction of RBCs and
platelets reduces the incidence of  FNHTR.13 Volume
reduction of platelets also may reduce the incidence
of  these reactions. For reactions associated with a
temperature rise of greater than 2°C or with
hypotension, bacterial contamination also should be
suspected and a Gram stain and microbial culture
performed on the remaining blood product. Five per
cent of the babies in this study had increase in
temperatures of less than 2°C during the blood
transfusion. The rate is higher than the usual rates in
newborn.13 The high incidence of neonatal sepsis
present in this cohort of babies studied might be
responsible for the temperature rise. However, a small
percentage of these babies may still be due to FNHTR.
Allergic reactions are rare in neonates. They occur when
a patient has preformed immunoglobulin (Ig) E
antibody against an allergen in the donor plasma.
Residual cytokines or chemokines (eg, RANTES)
released by stored platelets also may contribute to
allergic reactions. Most reactions respond to
antihistamines. Severe anaphylactic reactions are rare;
some are related to anti-IgA antibodies. These severe
reactions are treated with epinephrine, steroids, or both
as well as intubation and vasopressors if needed.
Patients who have a history of anti-IgA antibodies or
anaphylaxis to blood transfusion should receive
washed cellular products.14  None of  the patients had
allergic reactions.
Transfusion-related acute lung injury (TRALI) is the
most commoncause of transfusion-related fatality but
often remains unrecognized. The recommended
diagnostic criteria for TRALI are the acute onset of
hypoxemia with bilateral infiltrates on chest radiograph
within 6 hours of a blood transfusion and no evidence
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of circulatory overload. Patients who have circulatory
overload respond to diuresis, but those who have
TRALI do not. The treatment of TRALI is oxygen
support and mechanical ventilation, resulting in
recovery within 96 hours for most patients. None of
the patients had evidence of circulatory overload
throughout the transfusion period.
It is hypothesized that TRALI may be the result of
two cumulative events: the first linked to the patient,
such as underlyingsepsis, trauma, hematologic disease,
or postsurgical status, and the second being haemolysis
related to T-antigen activation is a rare complication
of  sepsis and necrotizing enterocolitis (NEC) in infants.
The enzymesialidases released by bacteria can alter RBC
membranes by cleaving sialic acid residues, thereby
exposing (“activating”) the T antigen. Most plasma-
containing components contain naturallyoccurring anti-
T agglutinins that can cause haemolysis of  T-activated
cells. Although T activation has been detected on the
RBCs of up to 30% of neonates who have NEC,
clinical haemolysis rarely is observed.15,16 Four percent
of the patients had haemosiderin and haematuria but
without clinical evidence of  worsening haemolysis. 
Neonates are at increased risk of fluid overload from
transfusion because the volume of the blood
component issued by the Transfusion Service Unit may
exceed the volume that may be transfused safely into
neonates. Care should be taken to ensure that, in the
absence of blood loss, volumes infused do not exceed
10 to 15mL/kg. Metabolic complications are
encountered primarily with massive transfusions (>15
to 20mL/kg) or exchange transfusions. The Patients
that had blood volumes of up to 15–20mL/kg all
had intravenous laxis before the transfusion and none
presented with fluid overload. Hypocalcaemia can
result from large infusions of citrate, which prevents
clotting in blood components by binding calcium. The
most feared symptom of hypocalcaemia is myocardial
depression.A prolonged QT interval may be observed
on electrocardiography. Cardiac monitoring or regular
checks of ionized calcium level are recommended in
neonatal patients receiving massive transfusions. The
patients that received EBT had 1 ml of calcium
gluconate infused after every 100mls of whole blood
exchanged. Hyperkalaemia can occur with rapid or
massive infusion of  stored RBCs17. Washing to reduce
supernatant potassium may be appropriate in massive
transfusions in neonates. The quantity of  free potassium
is not clinically important for small-volume
transfusions administered slowly (eg, 3 to 5 mL/kg
per hour)17. Hypoglycemia and hyperglycemiaboth have
been reported in association with neonatal transfusions.
An inadequate infusion rate of glucose may result if
other sources of glucose are discontinued during
transfusion. Hypoglycemic episodes occur more
commonly with transfusion of  CPDA-1 RBCs rather
than additive RBCs, which contain larger quantities of
glucose. Large-volume transfusions of additive RBCs
may causetransient hyperglycemia followed by rebound
hypoglycemia from the insulin induced by the glucose
load.18
The infusion of cold blood components in surgery or
massivetransfusion may cause hypothermia, which may
be associated withhypoglycemia, apnea, and arrhythmia
complicated by cardiac arrest. This can be prevented
by using a monitored blood warming system with
alarms.19 All the blood products given in these babies
were pre-warmed so none of  the complications were
seen in them.
Transmission of  infections such as HIV, Hepatitis B &
C, Cytomegalovirus (CMV), Syphilis  etc are possible
through blood  transfusion.20 In the study centre, all
blood/blood products are routinely screened for some
of  these infections. CMV screening is not routinely
done in our Centre.
CONCLUSION AND RECOMMENDATIONS
Blood transfusions are common among hospitalized
neonates, particularly in those of  preterm birth.
Clinicians should use a kinetic approach to diagnosing
neonatal anaemia, taking full advantage of the data
available on the routine CBC laboratory results. Every
NICU should have erythrocyte transfusion guidelines,
and these should be followed in order to avoid
unnecessary and unhelpful erythrocyte transfusions.
Despite significant improvement brought to blood
testing and handling, there remain both infectious and
non-infectious risks associated with allogeneic blood
transfusions. Data analysis has demonstrated that the
incidence of adverse events is greater in children and
especially infants. The long-term repercussions may be
significant in the paediatric population. Blood-
conservation modalities can be used safely in paediatric
patients. Combined techniques seem to be more
effective than any single modality. No blood-sparing
protocol would be complete and efficient without the
use of an evidence-based transfusion algorithm. Studies
have demonstrated that paediatric patients tolerate
lower haemoglobin levels without incurring adverse
events. Finally, intense research into manufacture of
red blood cells by pluripotent stem cell is ongoing
and promising. The development of  alternatives to
transfusions was initiated over 50 years ago and has
still not come to fruition. Only a few products are
currently undergoing phase III trials.21
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